About
A window into the science of healthier aging
Why I started AgeBeacon
Curious about what comes next
I’m a longevity enthusiast, fascinated by what feels like one of the next frontiers in science. Understanding aging could one day change how long we stay healthy, how we live, and what we are able to do across a lifetime. The possibilities are exciting, and I think the years ahead will bring discoveries worth following closely.
That excitement also made me want a clearer way to follow the field. I kept encountering attention-grabbing headlines that promised more than the underlying research could support. A result in cells or animals can be fascinating, but it is different from evidence that something helps people.
I created AgeBeacon to explore both the promise and the evidence: what was actually studied, what the findings mean, and what remains uncertain. I hope this can become a community for people who share my fascination, want to learn together, and can be optimistic about the future while asking careful questions about the science.
Slobodan Stefanov · Founder, AgeBeacon
AgeBeacon is an evidence-navigation project for people who want to understand where human longevity science is moving and how strong the evidence actually is.
We separate research activity, efficacy, safety and certainty rather than collapsing them into a single claim about what “works.” When evidence is uncertain, we show that uncertainty.
AgeBeacon is not medical advice. Decisions about medicines and health conditions should be made with qualified healthcare professionals.
Who is responsible
AgeBeacon was founded and is published by Slobodan Stefanov. Specialist external review, where used, is identified on the relevant page.
How the briefs are made
Editorial summaries link to original research and distinguish human outcomes from animal, laboratory and observational evidence. Claims are intended to remain traceable to the underlying study, registry record or publication.
Corrections and independence
We correct material errors and update assessments when important new evidence emerges. AgeBeacon does not sell longevity products, and product sales do not influence evidence assessments.